NCT06861881View on ClinicalTrials.gov

Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Glucose Metabolism Disorders (Including Diabetes Mellitus)
Interventions
DEVICE

Dexcom G7 Continuous Glucose Monitor

Dexcom G7 continuous glucose monitor will be placed prior to cardiac surgery. It will be worn continuously throughout the perioperative period and during the time admitted to the Cardiovascular Intensive Care Unit.

Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER